Table 1 Presence of cytogenetic... | American Society of Hematology

Table 1

Presence of cytogenetic abnormalities in pPCL by FISH

Reference	N	del(13q); NDMM: ∼ 50%	14q32 translocations; NDMM: 50%-60%	t(4;14); NDMM: ∼ 15%	t(11;14); NDMM: ∼ 15%	t(14;16); NDMM: ∼ 5%	del(17p); NDMM: ∼ 10%	amp(1q21); NDMM: ∼ 30%-43%	del(1p21); NDMM: ∼ 20%
5	18	85	87	0	65	0	50	NA	NA
4	70	65	NA	21	25	17	20	NA	NA
6	13	86	NA	NA	NA	NA	NA	NA	NA
13	40	68	80	12	33	13	NA	NA	NA
16	15	57	NA	25	50	NA	29	57	21
22	22	73	NA	14	32	36*	32	46	41
17	10	60	70	0	40	30	20	67†	44†

Reference	N	del(13q); NDMM: ∼ 50%	14q32 translocations; NDMM: 50%-60%	t(4;14); NDMM: ∼ 15%	t(11;14); NDMM: ∼ 15%	t(14;16); NDMM: ∼ 5%	del(17p); NDMM: ∼ 10%	amp(1q21); NDMM: ∼ 30%-43%	del(1p21); NDMM: ∼ 20%
5	18	85	87	0	65	0	50	NA	NA
4	70	65	NA	21	25	17	20	NA	NA
6	13	86	NA	NA	NA	NA	NA	NA	NA
13	40	68	80	12	33	13	NA	NA	NA
16	15	57	NA	25	50	NA	29	57	21
22	22	73	NA	14	32	36*	32	46	41
17	10	60	70	0	40	30	20	67†	44†

Values are percentages.

NDMM indicates newly diagnosed myeloma; and NA, not available.

Both t(14;16) and t(14;20).

Determined by aCGH in 9 patients.